Ms. Gendrolis’ expertise provides a valuable addition to the services that we provide to companies developing reimbursement strategy as part of early-stage development planning.
WASHINGTON (PRWEB)
October 05, 2022
NDA Partners’ General Manager, Eric Fish, announced today that Catherine Gendrolis, a medical device and diagnostic reimbursement expert, has joined the firm as an Expert Consultant. She is experienced in coding and reimbursement analysis across government-sponsored and commercial health plans, sustainable finance planning, outcomes and impact analysis, payor landscape assessment, and payor contracting and negotiation strategy including value-based purchasing arrangements.
Ms. Gendrolis formerly served as Director at Precipio Health Strategies where she conducted due diligence for private equity firms focused on lower middle market investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science companies. Currently, she serves as a strategic advisor to health plan and provider clients in the development, financing, contracting and implementation of innovative solutions and benefits that address the needs of Medicare and Medicaid beneficiaries. She served as Adjunct Faculty at the University of Baltimore where she taught Health Insurance and Prepaid Health Care and Introduction to Quality Performance and Improvement in Health Care, has authored reimbursement-focused works including The Hospice Guide to Billing and Reimbursement, and presented at numerous health care and life sciences conferences.
“Ms. Gendrolis’ expertise provides a valuable addition to the services that we provide to companies developing reimbursement strategy as part of early-stage development planning. We are pleased to welcome her to our team of Expert Consultants,” said Ms. Deb Koeneman, Manager of NDA Partners’ medical device practice.
Ms. Gendrolis earned her master’s degree in Health Systems Management from the University of Baltimore and a bachelor’s degree in Spanish from Tulane University.
About NDA Partners
NDA Partners, a ProPharma Group company, is a life sciences management consulting and contract development organization focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.
Contact
Eric Fish, General Manager
Office: 540-738-2550
FishEric@ndapartners.com
Share article on social media or email: